Drug Bivalirudin Better Than Heparin After Heart Attack, Large Study Suggests
Tuesday, May 27, 2008 - 09:35
in Health & Medicine
Heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors.
Read the whole article on Science Daily
More from Science Daily
Related
- Findings released from 1 of the largest percutaneous coronary intervention trials everFri, 23 May 2008, 12:21:58 EDT
- Landmark study reveals superiority of bivalirudin in heart attack patients at 30 daysThu, 22 May 2008, 8:21:50 EDT
- Drug-eluting stents better than bare-metal stents for heart attack patientsFri, 25 Sep 2009, 15:35:45 EDT
- Surprising rate of recurring heart attacks, strokes globallyMon, 31 Aug 2009, 14:51:53 EDT
- Heart attack rates drop after smoking bans, continue downward over timeMon, 21 Sep 2009, 16:38:56 EDT